糖尿病足感染临床药物治疗的进展  

Recent Advances of Clinical Treatment of Diabetic Foot Infections

作　　者：李性天[1] 耿立坚[1] 张友智[1] 周密妹[1] 

机构地区：[1]武汉科技大学附属天佑医院,武汉430060

出　　处：《抗感染药学》2012年第3期172-176,共5页Anti-infection Pharmacy

摘　　要：糖尿病足部感染是糖尿病的常见并发症,诊治轻症感染患者可选用对葡萄球菌、链球菌有活性的窄谱抗感染药物;对慢性、中重度感染或接受抗感染药物治疗无效的患者,经验性治疗应选用广谱抗感染药物。综述抗糖尿病足感染的常规治疗、重症治疗用药,以及治疗其新药研发的进展。Diabetic foot infections are a serious complication of diabetes mellitus. Antibiotic therapy for initial mild infections can often choose those against Staphylococci and Streptococci. Empiric therapy for infections that are chronic, moderate or severe, as well as that occur in patients who have failed in previous antibiotic treatment, should usually choose the antibiotics of more broad spectrum. The author reviewed the potential role of standard and newer an- tibiotics that may be appropriate for treating diabetic foot infections, and also the advances in the new drugs clinical re- search.

关 键 词：糖尿病足 感染性疾病 抗生素治疗 

分 类 号：R969.3[医药卫生—药理学]